Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Valuation vs Instaport thresholds (P/E, PEG, P/FCF, P/S)
Licensed market data — shown to members, not published to the open web.
Profile
From SEC filingsCompany description
We are the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about providing the opportunity to restore nerve function and quality of life for patients with peripheral nerve injuries. We provide innovative, clinically proven, and economically effective repair solutions for surgeons and healthcare providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve or the inability to properly reconnect peripheral nerves can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.
Read the full filing description · filed 24 Feb 2026
At a glance
- Sector
- Healthcare
- Industry
- Electromedical & Electrotherapeutic Apparatus
- CEO
- Michael J. Dale
- Employees (2026)
- 622
- Incorporated in
- MN
Sector is derived from the SEC industry classification.
13631 PROGRESS BLVD., ALACHUA, FL, United States · (386) 462-6817 · axogeninc.com
Source: SEC filings. Information and analytics, not investment advice.